You can buy or sell KRBP and other stocks, options, and ETFs commission-free!
Kiromic Biopharma, Inc. operates as a biotechnology company, which engages in the development of cancer engineered immunotherapies. Its technologies include Intelligent Immunotherapy, Diamond AI, CancerSplice, ABBIE, and CAR-T Proprietary Binder Technology. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX. The listed name for KRBP is Kiromic BioPharma, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 11, After Hours